Bayer Ups Guidance While Pharma Head Highlights NHL Drug Copanlisib

 
• By Lucie Ellis-Taitt
  
Cancer cell
Bayer's pharma head zooms in on regulatory progress for NHL drug in 1Q earnings call
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business